- Home
- NBR vs PRME Comparison
NBR vs PRME Comparison
Compare NBR & PRME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NBR
- PRME
- Stock Information
- Founded
- NBR 1952
- PRME 2019
- Country
- NBR Bermuda
- PRME United States
- Employees
- NBR N/A
- PRME N/A
- Industry
- NBR Oil & Gas Production
- PRME Medicinal Chemicals and Botanical Products
- Sector
- NBR Energy
- PRME Health Care
- Exchange
- NBR Nasdaq
- PRME Nasdaq
- Market Cap
- NBR 529.5M
- PRME 624.0M
- IPO Year
- NBR N/A
- PRME 2022
- Fundamental
- Price
- NBR $36.81
- PRME $3.21
- Analyst Decision
- NBR Hold
- PRME Buy
- Analyst Count
- NBR 8
- PRME 6
- Target Price
- NBR $45.63
- PRME $8.88
- AVG Volume (30 Days)
- NBR 558.0K
- PRME 3.5M
- Earning Date
- NBR 10-21-2025
- PRME 08-07-2025
- Dividend Yield
- NBR N/A
- PRME N/A
- EPS Growth
- NBR N/A
- PRME N/A
- EPS
- NBR N/A
- PRME N/A
- Revenue
- NBR $3,030,598,000.00
- PRME $4,961,000.00
- Revenue This Year
- NBR $11.94
- PRME $179.58
- Revenue Next Year
- NBR $2.68
- PRME N/A
- P/E Ratio
- NBR N/A
- PRME N/A
- Revenue Growth
- NBR 3.49
- PRME 739.42
- 52 Week Low
- NBR $23.27
- PRME $1.11
- 52 Week High
- NBR $86.10
- PRME $5.17
- Technical
- Relative Strength Index (RSI)
- NBR 57.57
- PRME 46.50
- Support Level
- NBR $34.40
- PRME $3.09
- Resistance Level
- NBR $36.75
- PRME $3.66
- Average True Range (ATR)
- NBR 2.14
- PRME 0.26
- MACD
- NBR 0.22
- PRME -0.03
- Stochastic Oscillator
- NBR 89.29
- PRME 44.65
About NBR Nabors Industries Ltd.
Nabors Industries Ltd owns and operates land-based drilling rig fleets and is a provider of offshore platform rigs in the United States and international markets. It also provides performance tools, directional drilling services, tubular running services, and technologies. The company has four reportable segments: U.S. Drilling, International Drilling, Drilling Solutions, and Rig Technologies. The key revenue of the company is generated from International Drilling.
About PRME Prime Medicine Inc.
Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology.